21.11.2014 Views

o_1977r8vv9vk1ts2ms0kd8pksa.pdf

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

164 D. Ley, K. MarsÏ—l<br />

Table 12.1. Intrauterine blood flow and postnatal neurodevelopment. ADHD attention deficit hyperactivity disorder, AEDF absent end-diastolic flow, AGA appropriate-forgestational<br />

age, AREDF absent or reverse end-diastolic flow, BFC blood flow class, CI confidence interval, C/P ratio cerebroplacental ratio =ratio between the middle cerebral<br />

artery and umbilical artery PI, c.s. cesarean section, EDF end-diastolic flow, GA gestational age, IUGR intrauterine growth restriction, PI pulsatility index, REDF reverse enddiastolic<br />

flow, RI resistance index, RR risk ratio, S/D systolic-to-diastolic ratio, UA umbilical artery, U/C PI ratio ratio between the umbilical artery and middle cerebral artery PI,<br />

vag. vaginal delivery<br />

Study Study group Control group Follow-up study<br />

Age Test Finding in the study group<br />

Reference Number Doppler<br />

finding<br />

GA at birth<br />

(weeks)<br />

Number Doppler<br />

finding<br />

GA at birth<br />

(weeks)<br />

Umbilical artery<br />

[46] 37 AREDF 26±40 37 Normal RI 32.4 (3.3) Up to 6 months Neurology at discharge More infants with abnormal neurological<br />

evaluation<br />

[48] 25 Abnormal<br />

S/D, c.s.<br />

[49] 7 Abnormal<br />

PI<br />

< 34 17 Normal<br />

S/D, c.s.<br />

40 Preterm,<br />

vag.<br />

< 34 2 years Denver a Poor cognitive progress,<br />

< 34 Bayley b delayed motor development<br />

67 Term, vag. >37<br />

32.1 23 Normal 36.6 4±6 years Neurological exam No significant differences<br />

10 AREDF (3.4) (2.5) Denver a<br />

[47] 20 AREDF ~31 26 Positive<br />

EDF<br />

~33 1±2 years Uzgiris and Hunt c<br />

Militerni d<br />

Greater risk of permanent neurological<br />

sequelae<br />

Bottos e<br />

[50] 31 AEDF < 34 (?) 95 Positive<br />

EDF<br />

[39] 16 AREDF 27 16 Matched<br />

controls<br />

(AGA)<br />

[46] 23 AREDF 28±40 23 Matched<br />

controls<br />

< 34 (?) Every 6 months<br />

up to 4 years<br />

Amiel-Tisson f<br />

Griffith g<br />

No differences in the developmental<br />

quotients or motor outcomes;<br />

Snijders-Oomen h at 2 years lower performance subscale<br />

test<br />

Increased risk for mental retardation and<br />

27 13±91 months Lietz i<br />

Bayley b<br />

Kaufman j<br />

severe motor impairment<br />

28±40 6 years Kaufman j<br />

(3±8.5 years)<br />

Long-term impairment of intellectual development<br />

and partial neurodevelopmental<br />

delay<br />

test l<br />

Man-Drawing test k<br />

Zurich Neuromotor<br />

[60] 27<br />

9<br />

AEDF<br />

REDF<br />

27±37<br />

27±32<br />

40 Positive<br />

EDF<br />

26±38 5±12 years BAS-II m<br />

QNST-II n<br />

SDQ o<br />

Educational achievement<br />

Visual function, hearing<br />

AEDF ± not associated with adverse neurodevelopmental<br />

outcome;<br />

REDF ± associated with a wide range of<br />

problems

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!